ASCP explores the cancer biomarker testing navigator as a novel role to improve laboratory operations and workflows: A special report from the ASCP Biomarker Testing Navigator Project Team
Further exploration is warranted to refine the BTN role and assess its long-term sustainability in and impact on diverse laboratory settings.
Authors
- Melissa Kelly (ORCID: https://orcid.org/0000-0003-4708-2261)
- Mark D. Gilliland
- Karmele Valencia (ORCID: https://orcid.org/0000-0002-2882-7427)
- Lynnette S. Pineault (ORCID: https://orcid.org/0000-0001-8656-949X)
- Joseph Kim (ORCID: https://orcid.org/0000-0002-6017-6871)
- Ananya Datta Mitra (ORCID: https://orcid.org/0000-0002-8097-4950)
- Alexandra Brown
- Lindsay Yanamura
- Amy Ferea
- Jennifer Buhay
- Suzanne Ziemnik
- James Morgante
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Spartanburg Regional Healthcare System (US)
- HealthPartners (US)
- American Society for Clinical Pathology (US)
- University of California, Davis (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1093/ajcp/aqaf028
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca